N, I., JS, R., J, D., JW, C., K, S., FR, M., . . . C, S. (2024). Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7+3 Based on Post Treatment Events and Responses: Retrospective Cohort Study. JMIR cancer, 10, e54740. https://doi.org/10.2196/54740
Chicago Style (17th ed.) CitationN, Islam, Reuben JS, Dale J, Coates JW, Sapiah K, Markson FR, Jordan CT, and Smith C. "Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7+3 Based on Post Treatment Events and Responses: Retrospective Cohort Study." JMIR Cancer 10 (2024): e54740. https://doi.org/10.2196/54740.
MLA (9th ed.) CitationN, Islam, et al. "Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7+3 Based on Post Treatment Events and Responses: Retrospective Cohort Study." JMIR Cancer, vol. 10, 2024, p. e54740, https://doi.org/10.2196/54740.